A cost minimisation analysis of navelbine-cisplatin versus gemcitabine-cisplatin in advanced nonsmall cell lung cancer in Poland

被引：0
|
作者：
Skowron, A. [1 ]
Polak, S. [1 ]
Brandys, J. [1 ]
机构：
[1] Jagiellonian Univ, Krakow, Malopolska, Poland
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63461-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A285 / A285
页数：1
相关论文
共 50 条
  • [1] Effectiveness of Gemcitabine-Cisplatin Chemotherapy in Nonsmall Cell Lung Cancer
    Ucsular, Fatma Demirci
    Uslu, Ozgur
    Tuksavul, Fevziye
    Gulpek, Mehmet
    Kos, Timur
    Guclu, Salih Z.
    EURASIAN JOURNAL OF PULMONOLOGY, 2005, 7 (03) : 115 - 122
  • [2] Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Nonsmall Cell Lung Cancer
    Hasturk, Serap
    Hatabay, Nilgun
    Ece, Ferah
    Karatasli, Meltem
    Hanta, Ismail
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 280 - 285
  • [3] Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer
    López-Vivanco, G
    Viteri, A
    Barceló, R
    Muñoz, A
    Rubio, I
    Mañé, JM
    Fuente, N
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (05): : 501 - 507
  • [4] Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
    Ozkaya, Sevket
    Findik, Serhat
    Uzun, Oguz
    Atici, Atilla Guven
    Erkan, Levent
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2008, 2
  • [5] Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy
    Novello, S
    Kielhorn, A
    Stynes, G
    Selvaggi, G
    De Marinis, F
    Maestri, A
    Foggi, P
    Tilden, D
    Tonato, M
    Crinò, L
    Rinaldi, M
    Migliorino, AM
    Scagliotti, GV
    LUNG CANCER, 2005, 48 (03) : 379 - 387
  • [6] Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer
    Kroep, J. R.
    Smit, E. F.
    Giaccone, G.
    Van der Born, K.
    Beijnen, J. H.
    Van Groeningen, C. J.
    Van der Vijgh, W. J. F.
    Postmus, P. E.
    Pinedo, H. M.
    Peters, G. J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 509 - 516
  • [7] A cisplatin-gemcitabine phase II trial in locally advanced and advanced nonsmall cell lung cancer
    Vazquez, F
    Baron, FJ
    Cueva, JF
    Candamio, S
    Calvo, M
    Irigoyen, A
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 102 - 102
  • [8] Phase I study of gemcitabine-cisplatin versus pemetrexed-cisplatin for patients with advanced or metastatic bladder cancer
    Cao, Yifang
    He, Yi
    Chen, Hao
    He, Shunliang
    Gu, Yanqin
    Wang, Xueping
    Chen, Bin
    JOURNAL OF BUON, 2018, 23 (02): : 475 - 481
  • [9] Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer
    Thomas, Michael
    Fischer, Juergen
    Andreas, Stefan
    Kortsik, Cornelius
    Grah, Christian
    Serke, Monika
    von Eiff, Michael
    Witt, Christian
    Kollmeier, Jens
    Mueller, Ernst
    Schenk, Michael
    Schroeder, Michael
    Villalobos, Matthias
    Reinmuth, Niels
    Penzel, Roland
    Schnabel, Philipp
    Acker, Thomas
    Reuss, Alexander
    Wolf, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (01) : 219 - 229
  • [10] Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer
    Cardenal, F
    López-Cabrerizo, MP
    Antón, A
    Alberola, V
    Massuti, B
    Carrato, A
    Barneto, I
    Lomas, M
    García, M
    Lianes, P
    Montalar, J
    Vadell, C
    González-Larriba, JL
    Nguyen, B
    Artal, A
    Rosell, R
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 12 - 18
12345